Tag Archives: Nektar Therapeutics (NKTR)

Nektar Therapeutics (NKTR)

Nektar Therapeutics (NKTR) And AstraZeneca plc (AZN) Get Approval of FDA For Movantik

Nektar Therapeutics (NKTR) And AstraZeneca plc (AZN) Get Approval of FDA For Movantik

The U.S. Food and Drug Administration (FDA) has approved Movantik (naloxegol) tablets drugs that are used for the treatment of constipation, Nektar Therapeutics (NASDAQ:NKTR) has said. In the statement, the pharmaceuticals company announced that the drug has successfully gone through the agency’s approval intricacies to attain their approval as a treatment of constipation caused by

Top